JP Morgan

India’s IL&FS Transportation Networks had to postpone its dollar bond debut after a series of unfortunate events on Tuesday. A weak market backdrop, a cautious investor base and a hefty pipeline of deals combined to dash its hopes, writes Morgan Davis.

Kommunekredit has printed a €1bn five year note — but two more SSA borrowers are lining up further out in the curve.

The low rates in Europe are making the euro high yield market an attractive option for US issuers like Belden, a St Louis-based manufacturer of telecoms equipment, which is launching a new euro bond to buy back old deals in euros and dollars. More US issuers are coming to euros, say bankers and investors.

Georgia Capital, the investment arm of Bank of Georgia Group (BGEO), had the sole attention of EM investors on Monday when it printed its new deal 70bp-75bp wider than Bank of Georgia.

Al Ahli Bank of Kuwait is beginning a roadshow to market a dollar Reg S-only perpetual non-call five year additional tier one bond.

JP Morgan has promoted Silvia Viviano to become its new head of equity capital markets execution for EMEA, succeeding Chris Roberts, who left the bank earlier this year to join Moelis & Co.

China Minmetals Corp’s perpetual bond sale on Monday was a demonstration of the market’s strength after a volatile few weeks, but the deal came at a cost.

Gategroup Holding, the Swiss airline catering company, is planning to list on the SIX Swiss Exchange in an IPO that will allow its Chinese owner HNA Group to raise leverage-funds after a global acquisition spree.

Chinese online consumer finance provider VCredit Holdings filed a draft IPO prospectus with the Hong Kong Stock Exchange on Monday. It is expected to float on the bourse as early as April, according to a source close to the deal.

Standard Chartered has hired a JP Morgan banker to lead part of its North American corporates team.

Two SSA borrowers readied trades in the dollar market on Monday, lining up for a busy week of issuance.

Siemens has chosen to set a price range designed to please investors on the IPO of its medical technology division Siemens Healthineers, rather than seeking an aggressive valuation.